CAS 2919211-45-1

Formel: C20H29N3O8

InChl: InChI=1S/C16H23N3O2.C4H6O6/c1-10-5-4-6-18-15(10)21-9-16(2,3)19-14(20)13-11-7-17-8-12(11)13;5-1(3(7)8)2(6)4(9)10/h4-6,11-13,17H,7-9H2,1-3H3,(H,19,20);1-2,5-6H,(H,7,8)(H,9,10)/t11-,12+,13?;1-,2-/m.1/s1

InChI Key: HADNFKQQXFCLDD-JTXMZQTASA-N

SMILES: CC1=C(N=CC=C1)OCC(C)(C)NC(=O)C2[C@H]3[C@@H]2CNC3.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O

(1R,5S,6r)-N-(2-methyl-1-((3-methylpyridin-2-yl)oxy)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide L(+)-Tartaric acid

CAS: 2919211-45-1

(1R,5S,6r)-N-(2-methyl-1-((3-methylpyridin-2-yl)oxy)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide L(+)-Tartaric acid

Formel: C₂₀H₂₉N₃O₈

Reinheit: ≥98%

Molekulargewicht: 439.46

Ref: 54-BUP01625

Mazisotine tartrate

CAS: 2919211-45-1

(1R,5S,6r)-N-(2-methyl-1-((3-methylpyridin-2-yl)oxy)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide L(+)-Tartaric acid is a potential SSTR4 agonist.

Formel: C₂₀H₂₉N₃O₈

Reinheit: 99.72%

Farbe und Form: Solid

Molekulargewicht: 439.46

Ref: TM-T77670

(1R,5S,6r)-N-(2-methyl-1-((3-methylpyridin-2-yl)oxy)propan-2-yl)-3-azabicyclo[3.1.0]hexane-6-carboxamide L(+)-Tartaric acid

CAS: 2919211-45-1

Ref: IN-DA02E6DC